Metabolic Testing Market Overview
Metabolism is a chemical reaction and physical process that involves maintenance of the living state, such as breathing, blood circulation, contraction of muscles, digestion of food and nutrients, elimination of wastes such as urine, controlling body temperature, and functioning of brain and nerves of the organism. It is a pathway that begins with a sequence of chemical reactions with a specific molecule and ends with a product with the help of specific enzyme. Enzymes are vital to metabolism as they allow the organism to drive reactions for required energy. It is divided into two categories, i.e. catabolism and anabolism. A comprehensive metabolic panel is a blood test that measures your sugar (glucose) level, electrolyte and fluid balance, kidney function, and liver function.
The significant driver is rising prevalence of lifestyle based diseases coupled with increasing geriatric population with high susceptibility towards developing chronic diseases such as cancer and kidney disorders. Also surge in technological advancements such as the introduction of digital metabolic rate testing equipment and rapidly increasing healthcare expenditure levels in developed and developing nations is boosting the industry.
Metabolic Testing Market Forecast Report (2018-2023)
Global Metabolic Testing Market Forecast Report, the market worth USD 381.36 million in 2018 and estimated to grow at a CAGR of 7.5%, to reach USD 547.49 million by 2023.
Browse Report Brief and TOC @ https://www.marketdataforecast.com/market-reports/metabolic-testing-market-4378/
Metabolic Testing Market Segmentation
Global Metabolic Testing Market Segmentation, on the basis of product, application, technology, End user and region. Based on product, the market is segmented into CPET, Body Composition Analysis, ECG, Software and Portable System. Based on application, the market is segmented into critical care, dysmetabolic syndrome X, human performance testing, lifestyle diseases and other metabolic disorders. Based on technology the market is segmented into RMR analysis, VO2 max analysis and body composition analysis. The VO2 max analysis segment attributes the largest share of the market. It directly measures the body oxygen consumption, which other tests try to estimate. Based on End user, the market is segmented into laboratories, hospitals, gyms and sports training centers.
Geographically, the Metabolic Testing market is segmented into North America, Europe, Asia-Pacific, Latin America and Middle East Asia. North America is estimated to constitute the largest share in this market, while the Asia Pacific region is expected to witness the fastest growth and beat North America. The growth of Asia is because of increasing healthcare spending, growing demand for quality medical care, rising standard of living, favorable government initiatives and growing patient awareness levels
The major companies dominating this market for its products and services are
- Geratherm Medical AG (Germany),
- General Electric Company (U.S.),
- OSI Systems, Inc. (U.S.),
- Care Fusion Corporation (U.S.),
- MGC Diagnostics Corporation (U.S.),
- COSMED (Italy),
- CORTEX Biophysics’ GmbH (Germany),
- KORR Medical Technologies, Inc. (U.S.),
- AEI Technologies, Inc. (U.S.),
- Parvo Medics (U.S.),
- Microlife Medical Home Solutions, Inc. (U.S.).
Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients.
For more information:
Sales Manager at Market Data Forecast
Company Name: Market Data Forecast
Contact Person: Abhishek Shukla
Email: Send Email
Address:2nd Floor, Lakeview Plaza, Kavuri Hills